Abstract
Research Overview
This analysis is available through our Drug Discovery Technologies Growth Partnership Service program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.
To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.
Table of Contents
- 1. Executive Summary
- 1. Industry Snapshot
- 1. Key Findings
- 1. Industry Snapshot
- 2. Glossary and Exchange Rates
- 1. Glossary of Terms
- 1. Terms
- 2. Currency Exchange Rates
- 1. Exchange Rates
- 1. Glossary of Terms
- 3. Total Nucleic Acid Isolation Market in Europe
- 1. Market Overview
- 1. Key Market Trends
- 2. Research Methodology
- 1. Research Service Methodology
- 3. Segmentation
- 1. Market Segmentation
- 4. Market Engineering Measurements
- 1. Market Engineering Measurements
- 5. Industry Challenges
- 1. Key Challenges
- 6. Market Drivers
- 1. Market Drivers
- a. Need for More Sample Purity Spurs Market Growth
- b. Emerging Trends in Translational Medicine Providing the Impetus for Nucleic Acid Isolation Protocols
- c. Preconfigured Dedicated Solutions Aid Smaller Research Laboratories
- d. RNA Extraction Markets Witnesses a Positive Growth Trend
- 7. Market Restraints
- 1. Market Restraints
- a. Gearshift to Proteomics Approach Thwarts Nucleic Acid Penetration
- b. Gradual Shift in the Application Pursuits Deter the Market for Nucleic Acid
- c. Funding Insufficiencies and Some Anomalies in the Research Spending Cause Some Concern to the Suppliers
- 8. Revenue Forecasts
- 1. Revenue Forecasts
- 9. Pricing Trends
- 1. Key Pricing Trends
- 10. Technology Trends
- 1. Technology Trends
- 1. Market Overview
- 4. Nucleic Acid Instrumentation Markets
- 1. Market Engineering Measurements
- 1. Market Engineering Measurements for the Instrumentation Segment
- 2. Revenue Forecasts
- 1. Revenue Forecasting Analysis
- 3. Competitive Structure
- 1. Competitive Landscape
- 1. Market Engineering Measurements
- 5. Nucleic Acid Consumables Market for Isolation
- 1. Market Engineering Measurements
- 1. Market Engineering Measurements for Consumables
- 2. Revenue Forecasts
- 1. Revenue Forecast Analysis
- 3. Competitive Structure
- 1. Competitive Landscape
- 1. Market Engineering Measurements
- 6. Strategic Recommendations
- 1. Key Strategies
- 1. Competitive Scenario Analysis and Strategies
- 1. Key Strategies
- 7. DSD for Nucleic Acid Isolation Markets
- 1. Pharmaceutical R&D Expenditure
- 1. Pharmaceuticals R&D Expenditure
- 2. Pharmaceutical R&D Expenditure as a Percent of the Pharmaceutical
Market
- 1. Pharmaceuticals R&D Expenditure as a Percent of the Pharmaceuticals Market
- 3. Number of Biotech Companies
- 1. Number of Biotech Companies
- 4. Private Investment in Biotechnology
- 1. Private Investment in Biotechnology
- 5. Government Investments in R&D
- 1. Government Investments in R&D
- 1. Pharmaceutical R&D Expenditure
- 8. Database of Key Industry Participants
- 1. Key Industry Participants
- 1. List of Industry Participants in the European Nucleic Acid Isolation Market
- 1. Key Industry Participants

